Related Experiment Video
Updated: May 10, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53 codon 72 polymorphism and breast cancer risk: A meta-analysis
Jing Hou1, Yuan Jiang, Wenru Tang
1Laboratory of Molecular Genetics of Aging and Tumor, Medical Faculty;
The p53 codon 72 polymorphism does not appear to increase breast cancer risk. This meta-analysis found no significant association between variant genotypes and overall breast cancer risk in the evaluated populations.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- The p53 gene is a crucial tumor suppressor involved in breast cancer development.
- Conflicting findings exist regarding the association between the p53 codon 72 polymorphism (G>C) and breast cancer risk.
Purpose of the Study:
- To conduct a meta-analysis to definitively assess the relationship between the p53 codon 72 polymorphism and breast cancer risk.
- To consolidate evidence from existing studies to provide a more robust estimate of the association.
Main Methods:
- A systematic literature search was performed on the PubMed database.
- Sixty-one studies comprising 28,539 breast cancer cases and 32,788 controls were included.
- Pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated to assess the association, and publication bias was evaluated using funnel plots and Egger's/Begg's tests.
Main Results:
- The meta-analysis revealed no statistically significant association between variant p53 codon 72 genotypes (Pro/Pro + Arg/Pro) and breast cancer risk when compared to the Arg/Arg genotype (OR=1.016, 95% CI=0.931-1.11, P=0.722).
- Publication bias was assessed and found to be minimal, indicated by a symmetric funnel plot and non-significant Egger's (P=0.506) and Begg's (P=0.921) tests.
- The results indicate that common genotypes of the p53 codon 72 polymorphism do not confer an increased susceptibility to breast cancer.
Conclusions:
- This comprehensive meta-analysis suggests that the p53 codon 72 polymorphism does not significantly alter the risk of developing breast cancer.
- Further large-scale, global studies are warranted to confirm these findings and explore potential subtle associations or interactions.
More Related Videos
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle